Case Study: Atara Biotherapeutics achieves a foundation for growth and streamlined regulatory operations with Veeva Systems Vault RIM

Atara Establishes a Foundation for Growth with Veeva Vault RIM

Atara Biotherapeutics, a San Francisco–based biotech focused on T‑cell immunotherapy with 400+ employees, needed to better prepare its regulatory organization for growth. The company was underutilizing its Veeva Vault RIM system and sought to centralize regulatory data and documents, align cross‑functional teams, and automate manual processes ahead of anticipated commercialization.

Starting in 2020, Atara launched an optimization program to expand Vault RIM capabilities—enhancing Vault Submissions, adopting Vault Registrations for tracking, and implementing Vault Submissions Publishing—while shifting to an agile, risk‑based validation approach for faster, incremental deployments. The result is a unified, authoritative regulatory system that supports quicker, more informed decisions, improves operational processes and work‑product quality, and is becoming a strategic asset as the company scales.

Atara Biotherapeutics

Matt Neal

Senior Director Regulatory Affairs Operations